In this monthly roundup, investment across the beauty and personal care industry continues to reflect a clear shift toward long-term value creation. From infrastructure spending and strategic venture investments to IPO preparations and private capital, companies are deploying funds with a sharper focus on innovation, operational resilience and scalable growth. While financial markets remain selective, beauty continues to attract investment where brands, technology and infrastructure demonstrate durable competitive advantage.
Large-scale corporate investment remains centred on strengthening manufacturing and innovation capabilities. Unilever committed US$270 million to a new global beauty and personal care innovation centre, reinforcing the group’s long-term commitment to science-led product development and future category growth. The company also completed a £150 million investment in its Port Sunlight manufacturing hub, highlighting the importance of modernising production facilities to improve efficiency, sustainability and supply chain resilience.
Supply chain infrastructure is also attracting significant capital. Henkel invested €45 million in a new high-bay warehouse in Düsseldorf, strengthening its European logistics network and reinforcing the growing importance of automated distribution infrastructure. As beauty companies seek faster, more resilient supply chains, investment in logistics is becoming as strategically important as investment in manufacturing.
Public market ambitions continue to shape corporate strategy. Boots has entered sale talks as its owners weigh a potential £10 billion transaction instead of pursuing an IPO, illustrating the continued debate between private ownership and public market listings. Meanwhile, AS Watson, the owner of Superdrug, is pressing ahead with preparations for a potential US$30 billion dual IPO, signalling confidence in the long-term value of one of the world’s largest health and beauty retail groups.
IPO activity remains active across Asia. Oura has confidentially filed for an IPO as demand for smart rings and connected health technology continues to accelerate, reflecting the growing convergence between wellness and beauty. In China, Proya Cosmetics has re-filed for a Hong Kong IPO to support future growth and expansion, while Yatsen completed the first tranche of a private placement backed by Hillhouse, strengthening its capital position as it continues to evolve its brand portfolio.
Strategic investment in emerging brands also remains a priority for global beauty groups. The Estée Lauder Companies acquired a minority stake in clinical skincare brand 111SKIN, reinforcing its focus on premium, science-led skincare. Similarly, L’Oréal’s BOLD venture fund invested in body care brand Hanni, highlighting continued interest in challenger brands capable of disrupting established categories through innovation and strong consumer engagement.
Taken together, this monthly roundup demonstrates that funding within beauty remains both active and highly selective. Investment is increasingly directed toward innovation infrastructure, premium brand portfolios, supply chain resilience and next-generation consumer businesses. In 2026, funding the future is less about pursuing growth at any cost and more about investing in the capabilities, technologies and brands that will define the industry’s next decade.a
